The pDx app gives sufferers a cardiopulmonary evaluation system, engineered to medical grade requirements, to measure lung operate at dwelling utilizing a cell phone, laptop computer or pill.
electronRx will launch its pDx app for power respiratory illness (CRD) administration at at HLTH 2025 convention in Las Vegas, October 19-22, 2025.
The pDx app gives sufferers a cardiopulmonary evaluation system, engineered to medical grade requirements, to measure lung operate at dwelling utilizing a cell phone, laptop computer or pill. This permits clinicians to remotely assess cardiopulmonary operate, observe illness development, and alter therapy protocols to optimize therapeutic outcomes. By lowering the necessity for frequent hospital visits, pDx empowers sufferers to raised handle their circumstances, whereas serving to healthcare techniques to streamline supply and cut back the pressure on sources.
The pDx app and complementary scientific dashboard are designed to boost the detection, monitoring, and therapy of CRDs together with bronchial asthma, COPD, interstitial lung illness, and pulmonary hypertension, that are the third main explanation for dying, globally.1 The app expands upon electronRx’s proprietary purpleDx know-how, including tailor-made questionnaires and entry to real-time detailed outcomes for sufferers, in addition to their clinicians. Along with purpleDx’s cell phone accessibility, pDx can now be accessed utilizing any system with a display screen, reminiscent of a laptop computer or pill, relying on the person’s desire.
The know-how leverages the system’s digicam sensors to seize and measure blood circulate biomechanics, producing digital biomarkers that translate into clinically actionable metrics. These embody key physiological metrics reminiscent of coronary heart price, respiratory price, and tidal quantity. The information is delivered in actual time to healthcare suppliers through a safe scientific dashboard, enabling distant monitoring of lung operate and dynamic adjustment of therapy plans to optimize drug efficacy.
“electronRx is devoted to remodeling the lives of individuals dwelling with respiratory issues. pDx represents a significant step ahead in personalised respiratory care and we very a lot sit up for demonstrating the know-how at HLTH,” mentioned Dr Bipin Patel, CEO and Founder, electronRx. “The platform’s scalable structure helps integration into present care pathways, permitting for proactive intervention and lowered reliance on in-person visits. By facilitating steady monitoring, pDx helps clinicians personalise care whereas enhancing affected person adherence and lowering healthcare burden. Most significantly, it provides sufferers better flexibility and management over their healthcare journey.”
Reference
- International burden of power respiratory illnesses and danger elements, 1990–2019: an replace from the International Burden of Illness Research 2019 (eClinicalMedicine, 2023)
